1992
DOI: 10.1172/jci115595
|View full text |Cite
|
Sign up to set email alerts
|

Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix.

Abstract: Lipoprotein lipase (LPL), the rate-limiting enzyme for hydrolysis of plasma lipoprotein triglycerides, is a normal constituent of the arterial wall. We explored whether LPL affects (a) lipoprotein transport across bovine aortic endothelial cells or (b) lipoprotein binding to subendothelial cell matrix (retention). When bovine milk LPL was added to endothelial cell monolayers before addition of "2'I-labeled LDL, LDL transport across the monolayers was unchanged; but, at all concentrations of LDL tested (1-100… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

6
84
0
1

Year Published

1997
1997
2010
2010

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 144 publications
(91 citation statements)
references
References 42 publications
6
84
0
1
Order By: Relevance
“…Until now, most studies have focused on whether LPL affects cholesterol-rich remnant clearance in an antiatherogenic manner 6 or whether macrophage-derived LPL in the arterial wall is proatherogenic. 13,14 The antiatherogenic roles of LPL are mainly mediated by the enhanced hepatic clearance of remnant lipoproteins, 15 which leads to lowering plasma cholesterol, 16 whereas the proatherogenic functions of LPL are mainly attributed to the noncatalytic function of vascular cellderived LPL, which may not only promote the retention of atherogenic lipoproteins in the intima 17,18 but also aid in the uptake of lipoproteins by macrophages as well. 19 Moreover, the process of the hydrolysis of TG-rich lipoproteins by LPL also leads to the generation of IDLs and the enhancement of the conversion of large LDLs to small and dense LDLs.…”
mentioning
confidence: 99%
“…Until now, most studies have focused on whether LPL affects cholesterol-rich remnant clearance in an antiatherogenic manner 6 or whether macrophage-derived LPL in the arterial wall is proatherogenic. 13,14 The antiatherogenic roles of LPL are mainly mediated by the enhanced hepatic clearance of remnant lipoproteins, 15 which leads to lowering plasma cholesterol, 16 whereas the proatherogenic functions of LPL are mainly attributed to the noncatalytic function of vascular cellderived LPL, which may not only promote the retention of atherogenic lipoproteins in the intima 17,18 but also aid in the uptake of lipoproteins by macrophages as well. 19 Moreover, the process of the hydrolysis of TG-rich lipoproteins by LPL also leads to the generation of IDLs and the enhancement of the conversion of large LDLs to small and dense LDLs.…”
mentioning
confidence: 99%
“…Mo LPL produced in the vascular wall acts as a proatherogenic protein. Indeed, this enzyme mediates the uptake of lipoproteins by Mo (15)(16)(17), promotes lipoprotein retention to the extracellular matrix (18,19), induces the expression of the proatherogenic cytokine tumor necrosis factor-␣ (20,21), increases monocyte adhesion to endothelial cells (22)(23)(24), and increases proliferation of vascular smooth muscle cells (25). Recent evidence shows that Mo LPL promotes foam cell formation and atherosclerosis in vivo (26 -29).…”
mentioning
confidence: 99%
“…[7][8][9] Although plasma LPL activity tends to drive lipoprotein metabolism in a nonatherogenic direction, 10 -12 LPL produced in the vascular wall may act as a proatherogenic protein. Indeed, LPL has been shown to mediate uptake of lipoprotein particles by vascular cells, [13][14][15] to promote lipoprotein retention to the extracellular matrix, 16,17 to induce the expression of the proatherogenic cytokine tumor necrosis factor-␣, 18,19 and to enhance monocyte adhesion to endothelial cells. 20,21 Furthermore, recent studies indicate that LPL enhances cellular proteoglycan production 22 and promotes foam cell formation and atherosclerosis in vivo.…”
mentioning
confidence: 99%